Formulations of Ivacaftor and Pirfenidone not mapped to dm+d
Posted in News
A reminder that within Define, formulations of Ivacaftor (single ingredient formulations) and Pirfenidone are not currently mapped to dm+d. The price of these drugs is currently subject to negotiation and have not been mapped following a request from the government to maintain confidentiality.
In Refine, it is still possible for Trusts to monitor their use of these drugs, but not to compare the usage with other Trusts.